Remove tag expenses
article thumbnail

STAT+: A nonprofit does deals in Brazil and India to make low-cost CAR-T cell therapies widely available

STAT

In the latest bid to widen access to medicines, a nonprofit is sending technology and materials for making expensive CAR-T cell therapies to the Brazilian government and an Indian manufacturer that will, in turn, look to provide the treatments available at a fraction of current prices in the U.S.

130
130
article thumbnail

STAT+: CMS will use outcomes-based agreements in bid to help Medicaid pay for sickle cell gene therapies

STAT

In response to concerns over multimillion-dollar price tags for new gene therapies for sickle cell disease, the U.S. million, respectively, and have raised alarms over the ability of financially strapped state Medicaid programs to absorb the expense. Two therapies recently approved by health regulators cost $2.2 million and $3.1

127
127
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Haemophilia drug costing $3.5m per dose has been approved

Pharmafile

CSL Behring’s haemophilia B gene therapy has recently been approved by US regulators, however the treatment has an enormous price tag. per dose, the one-off infusion therapy has become the world’s most expensive medicine currently available. Costing $3.5m read more.

72
article thumbnail

bluebird bio wins back-to-back landmark FDA approvals for first-in-class gene therapies

Pharmaceutical Technology

Spark Therapeutics’ Luxturna, indicated for inherited retinal disease (IRD), was the first gene therapy to be approved, in 2017, with a price tag of $850,000 for each eye. bluebird then broke its own pricing record when the $3m Skysona was approved, and now faces the unique challenge of selling the world's two most expensive drugs.

FDA 115
article thumbnail

STAT+: Bone marrow transplant advance could widen use of this less buzzy cure for sickle cell disease

STAT

Meanwhile, researchers at the American Society of Hematology meeting on Tuesday are reporting advances in a less expensive and more established strategy proven to cure patients: bone marrow transplant. These drugs have price tags of $2.2 million and $3.1 million, respectively.

article thumbnail

STAT+: Pharmalittle: We’re reading about Wegovy supplies, Biogen ditching Aduhelm, and more

STAT

In response to concerns over multi-million-dollar price tags for new gene therapies for sickle cell disease, the U.S. million, respectively, and raised alarms over the ability of financially strapped state Medicaid programs to absorb the expense.  Two therapies recently approved by health regulators cost $2.2 million and $3.1

85
article thumbnail

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

Reimbursement has been a major obstacle in the EU for expensive gene therapies, including bluebird bio’s beta-thalassemia therapy Zynteglo. million price tag. Expensive treatment creates opportunities for gene therapy. The post Can gene therapies for haemophilia defend their high price tags? million ($1.8

FDA 111